| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tscan Therapeutics, Inc. (TCRX) has 12 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. TCRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.02M | $9.70M | - | |
| CEO | 1.17M | $1.41M | - | |
| Other | 420.0K | $508.2K | - | |
| Other | 350.0K | $423.5K | - | |
| CFO | 350.0K | $423.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 | Desmarais William | Chief Business Officer | Buy | 2,500 | $9.08 | $22,708.00 | New | -1.8% | -66.4% | |
| Jul 20, 2021 | Baker Bros. Advisors LP59 | Director | Buy | 1,425,000 | $15.00 | $21,375,000.00 | New | -38.4% | -66.9% | |
| Jul 20, 2021 | Westphal Christoph H | 10% Owner | Buy | 133,333 | $15.00 | $1,999,995.00 | +11.6% | -38.4% | -66.9% | |
| Jul 20, 2021 | Silver Brian M. | Chief Financial Officer | Buy | 1,000 | $15.00 | $15,000.00 | New | -38.4% | -66.9% |